These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
817 related items for PubMed ID: 24269849
21. Importance of tear film instability in dry eye disease in office workers using visual display terminals: the Osaka study. Yokoi N, Uchino M, Uchino Y, Dogru M, Kawashima M, Komuro A, Sonomura Y, Kato H, Tsubota K, Kinoshita S. Am J Ophthalmol; 2015 Apr; 159(4):748-54. PubMed ID: 25555800 [Abstract] [Full Text] [Related]
27. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients. Schargus M, Ivanova S, Kakkassery V, Dick HB, Joachim S. Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238 [Abstract] [Full Text] [Related]
29. Comparison of upper eyelid pressure and ocular surface parameters in dry eye disease and benign essential Blepharospasm: A cross-sectional study. Zhao G, Wang J, Ma Q, Hao Y, Tian L, Jie Y. Cont Lens Anterior Eye; 2024 Dec; 47(6):102298. PubMed ID: 39277528 [Abstract] [Full Text] [Related]
33. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops. Jee D, Park SH, Kim MS, Kim EC. Invest Ophthalmol Vis Sci; 2014 Jul 03; 55(8):5081-9. PubMed ID: 24994869 [Abstract] [Full Text] [Related]
34. Analysis of inflammatory cytokines in the tears of dry eye patients. Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA. Cornea; 2009 Oct 03; 28(9):1023-7. PubMed ID: 19724208 [Abstract] [Full Text] [Related]
35. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions. López-Miguel A, Tesón M, Martín-Montañez V, Enríquez-de-Salamanca A, Stern ME, Calonge M, González-García MJ. Am J Ophthalmol; 2014 Apr 03; 157(4):788-798.e2. PubMed ID: 24412126 [Abstract] [Full Text] [Related]
38. Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections. Yabumoto C, Osaki MH, Osaki T, Gameiro GR, Campos M, Osaki TH. Ophthalmic Plast Reconstr Surg; 2014 Apr 03; 39(5):475-478. PubMed ID: 36928309 [Abstract] [Full Text] [Related]
39. A direct comparison of onabotulinumtoxina (Botox) and IncobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm: a split-face technique. Saad J, Gourdeau A. J Neuroophthalmol; 2014 Sep 03; 34(3):233-6. PubMed ID: 24739994 [Abstract] [Full Text] [Related]